Area of research
Hematology · Oncology
Research interest
Research interests include Multiple Myeloma Research and Treatments, Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers, and Immunotherapy and Immune Responses.
A single-cell atlas characterizes dysregulation of the bone marrow immune microenvironment associated with outcomes in multiple myeloma
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study
TRK Fusion Cancer: Patient Characteristics and Survival Analysis in the Real-World Setting
Quality of Life in Adult and Pediatric Patients with Tropomyosin Receptor Kinase Fusion Cancer Receiving Larotrectinib
Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials
Larotrectinib versus Prior Therapies in Tropomyosin Receptor Kinase Fusion Cancer: An Intra-Patient Comparative Analysis
Activity of larotrectinib in TRK fusion cancer patients with brain metastases or primary central nervous system tumors.
Larotrectinib efficacy and safety in pediatric TRK fusion cancer patients.
Durability of response with larotrectinib in adult and pediatric patients with TRK fusion cancer
Activity of larotrectinib in TRK fusion lung cancer
Activity of larotrectinib in TRK fusion cancer patients with primary central nervous system tumours
Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial
Improving Patient Education With an Eczema Action Plan: A Randomized Controlled Trial